Dashboard
Manage Tickers

KVUE Kenvue Inc.

NYSE www.jnj.com/kenvue/


$ 16.65 $ -0.11 (-0.66 %)    

Friday, 14-Nov-2025 15:55:00 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 16.66
$ 16.82
$ 16.67 x 10,600
$ 16.69 x 11,811
$ 16.65 - $ 16.98
$ 13.85 - $ 24.41
34,737,941
na
31.92B
$ 0.90
$ 22.27
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2025 09-28-2025 10-Q
2 08-07-2025 06-29-2025 10-Q
3 05-08-2025 03-30-2025 10-Q
4 02-24-2025 12-29-2024 10-K
5 11-07-2024 09-29-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-01-2024 12-31-2023 10-K
9 11-03-2023 10-01-2023 10-Q
10 08-02-2023 07-02-2023 10-Q
11 06-02-2023 04-02-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-equal-weight-on-kenvue-raises-price-target-to-18
Barclays Maintains Equal-Weight on Kenvue,...
11/10/2025 18:47:59

Barclays analyst Lauren Lieberman maintains Kenvue (NYSE:KVUE) with a Equal-Weight and raises the price target from $17 to $18.

Core News & Articles
'Attor­ney Gen­er­al Ken Pax­ton Fights To...
11/06/2025 20:29:13

https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-fights-stop-manufacturer-tylenol-fraudulently-pa...

texas-attorney-general-ken-paxton-files-motion-to-prevent-kenvue-from-paying-out-november-dividend
Texas Attorney General Ken Pax­ton Files M...
11/06/2025 17:23:41

https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-fights-stop-manufacturer-tylenol-fraudulently-pa...

kenvues-487-billion-sale-puts-consumer-staples-etfs-back-in-vogue
Kenvue's $48.7 Billion Sale Puts Consumer ...
11/04/2025 19:26:03

The $48.7 billion Kimberly-Clark–Kenvue deal could reshape major consumer staples ETFs like XLP, VDC, and IYK.

options-corner-kimberly-clarks-implosion-offers-an-unusual-informational-arbitrage-opportunity
Options Corner: Kimberly-Clark's Implosion...
11/03/2025 20:56:05

Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative contraria...

kenvue-idexx-laboratories-freshpet-and-other-big-stocks-moving-higher-on-monday
Kenvue, IDEXX Laboratories, Freshpet And O...
11/03/2025 19:13:22

nvidia-amazon-extend-rally-bitcoin-sinks-to-107000-whats-moving-markets-monday
Nvidia, Amazon Extend Rally, Bitcoin Sinks...
11/03/2025 18:01:11

Wall Street opened the week on a mixed note on Monday.

Core News & Articles
Buffett Sells Stocks – Here Is What Pruden...
11/03/2025 16:13:32

Buffett Sells Stocks

Core News & Articles
'Activist Investors in Kenvue Faced Big Lo...
11/03/2025 15:37:46

https://www.wsj.com/business/deals/activist-investors-in-kenvue-faced-big-losses-kimberly-clark-saved-the-day-df6bb04a

kenvue-affirms-fy2025-adj-eps-guidance-of-100-105-vs-104-est
Kenvue Affirms FY2025 Adj EPS Guidance of ...
11/03/2025 13:04:54

Kenvue (NYSE:KVUE) affirms FY2025 Adj EPS guidance from $1.00-$1.05 to $1.00-$1.05 vs $1.04 analyst estimate..

kimberly-clark-stock-plunges-over-16-kenvue-surges-20-in-monday-pre-market-whats-going-on
Kimberly-Clark Stock Plunges Over 16%, Ken...
11/03/2025 12:16:56

Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it ann...

kenvue-q3-adj-eps-028-beats-027-estimate-sales-3764b-miss-3836b-estimate
Kenvue Q3 Adj. EPS $0.28 Beats $0.27 Estim...
11/03/2025 11:44:13

Kenvue (NYSE:KVUE) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.27 by 5.66 pe...

Core News & Articles
Kimberly-Clark To Acquire Kenvue In Cash A...
11/03/2025 11:33:54

Combines Highly Complementary and Strategically Aligned Consumer Offerings, Including 10 Iconic Billion-Dollar Brands, That Wil...

hhs-kennedy-on-tylenol-says-not-enough-evidence-to-show-tylenol-definitively-causes-autism-but-some-studies-seem-very-suggestive
HHS Kennedy On Tylenol Says Not Enough Evi...
10/29/2025 17:51:19

https://x.com/US_FDA/status/1983585600214061232

nvidia-to-rally-around-37-here-are-10-top-analyst-forecasts-for-wednesday
Nvidia To Rally Around 37%? Here Are 10 To...
10/29/2025 12:01:48

this-stride-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday
This Stride Analyst Is No Longer Bullish; ...
10/29/2025 11:32:29

canaccord-genuity-downgrades-kenvue-to-hold-lowers-price-target-to-15
Canaccord Genuity Downgrades Kenvue to Hol...
10/29/2025 11:11:03

Canaccord Genuity analyst Susan Anderson downgrades Kenvue (NYSE:KVUE) from Buy to Hold and lowers the price target from $26...

ken-paxton-alleges-johnson--johnson-misled-mothers-on-tylenol-safety
Ken Paxton Alleges Johnson & Johnson Misle...
10/28/2025 17:11:17

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for ...

Core News & Articles
Johnson & Johnson, Kenvue Sued By Texas At...
10/28/2025 12:53:44

https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-sues-big-pharma-manufacturers-deceptively-marketing-...

jefferies-maintains-buy-on-kenvue-lowers-price-target-to-23
Jefferies Maintains Buy on Kenvue, Lowers ...
10/27/2025 13:16:13

Jefferies analyst Keith Devas maintains Kenvue (NYSE:KVUE) with a Buy and lowers the price target from $25 to $23.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION